ARS Pharmaceuticals, Inc.SPRYEarnings & Financial Report
Nasdaq · Health Care · Pharmaceutical Preparations
ARS Pharmaceuticals, Inc. is a late-stage biopharmaceutical firm specializing in the development and commercialization of novel therapies for severe allergic reactions, most notably needle-free epinephrine delivery solutions for anaphylaxis. It primarily operates in the North American market, catering to both pediatric and adult patient groups at risk of life-threatening allergic responses.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| RA Capital Management, L.P. | 11.30% | 10.9M | ▲ +1.40pp | 2024-03-29 |
| The Pratik Shah Living Trust dated June 15, 2011 | 5.40% | 5.2M | ▼ -1.40pp | 2024-06-17 |
| Robert G. Bell | 4.50% | 4.3M | — | 2023-09-01 |
| FMR LLC | 1.25% | 1.2M | — | 2024-02-09 |
Insider Transactions
Net 90d: +$0 · buys $0 / sells $0Range:
Action:
Role:
No transactions match these filters.